Collectively, these findings demonstrate a dual role for ACTL6A in cervical cancer: as a prometastatic effector downstream of miR-216a-3p loss and as a critical node linking epigenetic regulation to YAP oncogenic signaling. This evidence concerns the gene ACTL6A and cervical cancer.